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The predominant risk factor of diabetic foot ulcers (DFU), peripheral neuropathy,
results in loss of protective sensation and is associated with abnormally high plantar
pressures. DFU prevention strategies strive to reduce these high plantar pressures.
Nevertheless, several constraints should be acknowledged regarding the research
supporting the link between plantar pressure and DFUs, which may explain the low
prediction ability reported in prospective studies. The majority of studies assess verti-
cal, rather than shear, barefoot plantar pressure in laboratory-based environments,
rather than during daily activity. Few studies investigated previous DFU location-spe-
cific pressure. Previous studies focus predominantly on walking, although studies
monitoring activity suggest that more time is spent on other weight-bearing activi-
ties, where a lower “peak” plantar pressure might be applied over a longer duration.
Although further research is needed, this may indicate that an expression of cumula-
tive pressure applied over time could be a more relevant parameter than peak pres-
sure. Studies indicated that providing pressure feedback might reduce plantar
pressures, with an emerging potential use of smart technology, however, further
research is required. Further pressure analyses, across all weight-bearing activities,
referring to location-specific pressures are required to improve our understanding of
pressures resulting in DFUs and improve effectiveness of interventions.
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1 | INTRODUCTION
Currently 425 million adults have diabetes mellitus worldwide, how-
ever the prevalence is rising, with 629 million cases expected by
2045.1 Diabetes is the main cause of non-traumatic lower limb ampu-
tations, of which up to 85% are the result of a diabetic foot ulcer
(DFU).2,3 Diabetic foot ulcers are a costly public health concern, with
a large proportion leading to amputation or infection; DFUs are also
associated with a reduced quality of life.4,5 The lifetime risk of devel-
oping a DFU is 15-25%.6,7 However, once ulcerated, DFU recurrence
rates are 40% within the first year and up to 65% after 5 years post-
healing.8,9 Risk factors for DFU include diabetic peripheral
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neuropathy, foot deformity and trauma, with diabetic peripheral neu-
ropathy being the predominant risk factor.5,10-12
The purpose of this review is to explore the role of high plantar
pressure, which accumulates due to a number of risk factors, in the
prediction and prevention of DFU. The authors review the different
methods of plantar pressure assessment in both barefoot and in-shoe
conditions, as well as the pressure parameters analysed in previous lit-
erature. Studies assessing plantar pressure typically find pressure to
be higher for people with diabetes and higher still for ulcerated
cohorts. However, despite this, vertical plantar pressure alone is still
reported as a poor predictor of DFU in prospective studies. The
review discusses the relative merits and limitations of previous stud-
ies, which may have contributed to low predictive ability and the
extent to which previous methods may relate to pressures experi-
enced throughout “real-life” daily activity.
1.1 | Factors resulting in high plantar pressure
Diabetic peripheral neuropathy leads to a loss of protective sensation
resulting in abnormally high, repetitive and undetected pressures
applied to the weight-bearing plantar surface of the foot. In addition,
foot deformities such as hammertoe and small muscle wasting further
contribute to increased plantar pressure, particularly at the metatarsal
heads where bony prominences reside.13 Other factors including a
reduced ankle dorsiflexion and reduced plantar tissue thickness are
also reported to contribute towards increasing plantar pressure.10,14
High plantar pressures lead to thickening of callus, putting added
pressure on the underlying soft tissue and leading to tissue break-
down and ulceration.15,16
Current DFU prevention interventions focus on reducing these
high plantar pressures.17 In the high-risk diabetic foot, custom-made
footwear and/or insoles are often prescribed which aim to offload
pressure from high-risk areas by accommodating foot deformities.
When worn, these interventions have been shown to significantly
reduce ulceration rates.18,19 However, footwear interventions are
often associated with poor adherence, thus limiting their effective-
ness.20-22 Although the aim of prescription footwear is to reduce plan-
tar pressure, the previous supporting research on the link between
high plantar pressure and DFU risk is associated with some limitations,
as discussed in the sections below.
2 | BAREFOOT PRESSURE ANALYSIS
Many studies investigating plantar pressure within the diabetic cohort
have done so using barefoot pressure analysis, predominantly using
pressure platforms (Figure 1).23-27 Such measurements take place
inside a laboratory and involve the participant walking along a walk-
way ensuring successful foot placement within the platform. How-
ever, methodology and patient characteristics vary within the
literature (Table. 1). Vertical plantar pressure is primarily assessed,
however studies either focus on the foot as a whole, or investigate
pressure at specific plantar locations, with the majority focusing on
the forefoot. Only a minority of studies analyse pressure specific to
ulcer location. Although some variability exists, the consensus from
the literature is that diabetes patients, particularly those with a history
of DFU, have higher plantar pressures than controls.12,35,38
2.1 | Whole-foot barefoot analysis
A number of previous studies conducting barefoot pressure analysis
have calculated peak plantar pressure of the whole-foot, rather than
specifying location. Such studies vary in methodology, with some
averaging peak plantar pressure from mid-gait steps with the platform
placed along a walkway,31,35 whereas other studies implement a two-
step approach to the platform.12,25 Research suggests the two-step
approach not only reduces time spent barefoot walking and the asso-
ciated risk to insensate feet, but also reduces the difficulty of making
full contact within the boundaries of the platform.39,40 However,
familiarisation and repetition of walking trials are still required to
ensure as natural gait as possible, thus still imposing some element of
potential risk on the high-risk diabetic foot as part of the barefoot
testing procedure.
Prospective studies consistently report significantly greater base-
line peak plantar pressure in diabetes participants who ulcerated
within the follow-up period, compared to those that remained ulcer-
free (Table. 2).12,25,35 However, the majority of these studies included
patients with and without a history of DFU. Individuals with a history
of DFU are reported to have significantly higher plantar pressures
than those without DFU history; therefore including participants with-
out DFU history in such studies may have diluted the results and con-
tributed to the low sensitivity of pressure predicting ulceration.30
Grouping together participants with active and previously healed
DFUs, as demonstrated in a previous cross-sectional study by
Frykberg et al.31 may weaken conclusions drawn about the causal
relationship between high plantar pressure and DFU, due to patients
with active DFUs potentially altering their gait (albeit without any sen-
sory feedback) to avoid any further damage to the active wound.27
Alterations in gait, and consequently plantar pressures, are expected
to differ depending on DFU status; therefore, analysis should ideally
group patients accordingly.41 Frykberg et al.31 also found significantly
greater peak plantar pressure for the ulcerated cohort compared to
the non-ulcerated cohort. In contrast to many whole-foot barefoot
studies, Lavery et al.25 described recording the location of the peak
pressure, however, as is the case with most whole-foot barefoot stud-
ies, did not report the location nor conduct any location-specific pres-
sure analysis. More comprehensive pressure analyses, which take into
account any effects of location on pressure and DFU, as well as more
stringent patient grouping, may improve DFU prediction.
Another suggested explanation for vertical plantar pressure being
a poor predictor of DFU, is not taking shear plantar pressure into con-
sideration.42,43 The majority of studies focus on vertical plantar pres-
sure rather than shear, potentially due to its greater magnitude and
ease of measurement with commercial systems compared to shear
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pressure.44 However, investigating shear pressure may increase the
understanding of plantar foot mechanics and their role in the devel-
opment of DFU.45 The few studies that did measure both parameters,
found no general trend in the locations of the peak shear and vertical
plantar, with the majority of participants having peak shear and peak
vertical pressure occurring at different sites.42,43,45 Furthermore, even
fewer papers related peak shear pressure to DFU. Yavuz et al.43
found more sites of peak shear to match sites of recently healed fore-
foot DFUs compared to peak vertical only sites, however, such differ-
ences were small. In addition, DFUs also occurred at sites where both
peak shear and peak vertical plantar pressures were at the same loca-
tion, as well as sites of neither peak parameters. Such results perhaps
highlight the complex, multifactorial nature of DFU. Similarly Yavuz
et al.46 also investigated shear in relation to DFU, however on this
occasion compared the magnitudes of peak shear and vertical plantar
pressure between diabetes participants with and without a history of
DFU, which authors believed to be the first of its kind. Both peak
shear and vertical plantar pressures were higher in the DFU group,
but only shear reached significance. However, the authors did suggest
their study might have been underpowered to detect a significant dif-
ference in peak vertical pressure, but believed the result to be clini-
cally meaningful. The above studies measured shear pressure while
barefoot and so results are unlikely to represent shear pressure
applied in-shoe, which may also differ depending on footwear.45
Therefore, further investigation into in-shoe shear pressure with
larger cohorts and of a longitudinal design are required before we can
fully understand the role of shear pressure in the development of
DFU. However currently, only a limited number of commercial
devices are available that are capable of measuring in-shoe shear
pressure. Nevertheless, existing research does suggest measuring
both shear and vertical plantar pressure along with other risk factors
could be beneficial in improving the understanding and prediction of
DFU. Although as suggested throughout this review, more ecologi-
cally valid research (ie, research that translates well to real-life
F IGURE 1 Examples of
equipment used to measure plantar
pressure. A, AMTI force platform
(Advanced Medical Technology, Inc.
Watertown, MA). B, BTS P-walk
pressure plate (MA). C, PressureStat
(Medical Gait Technology BY, Emmen,
The Netherlands). D, F-scan pressure
assessment system insole (Tekscan,
Inc., Boston, MA). The equipment A-C
are typically used to collect barefoot
pressure data, whereas D is placed
in-shoe
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settings) is needed before ruling out plantar pressure as a sole predic-
tor of DFU.
2.2 | Location-specific barefoot pressure analysis
To provide more detail, studies have identified peak vertical plantar
pressures that are region specific. Such research often reports high
ulceration rates at the forefoot, for example, Caselli et al.24 reported
98% of DFUs within a 30-month follow-up to be located at the fore-
foot. Therefore, the forefoot has been a particular focus of interest
for measuring region-specific pressures.
Certain cross-sectional studies have focused on barefoot forefoot
pressures alone, results of which follow a similar pattern to that of
whole-foot analysis, with the ulcerated cohort displaying significantly
higher peak plantar pressure.29,37 However, similar to Frykberg
et al.,31 studies included active and healed DFUs within their “ulcer-
ated” cohorts, which may have contributed to forefoot pressure alone
not being able to identify accurately patients at risk of ulceration.29
On the other hand, following a 30-month prospective study Caselli
et al.24 reported that forefoot peak pressure was able to accurately
predict ulceration, as was the ratio of forefoot to rearfoot pressure.
However, patients were grouped by severity of neuropathy, without
reference to their DFU history. Forefoot and rearfoot pressure were
both significantly higher for moderate to severe cases of neuropathy,
which are predominantly at high risk of ulceration.12 In addition, the
forefoot to rearfoot ratio highlighted an imbalance in pressure distri-
bution, particularly for those with severe neuropathy. Such findings
highlight the need for location specific pressure analysis rather than
analysing the foot as a whole.
A small number of studies have provided further detail by separat-
ing barefoot pressure into more regions. Sacco et al.36 sectioned the
foot into rearfoot, midfoot and forefoot, whereas Bacarin et al.30
looked at five regions, by splitting the forefoot into medial, lateral and
the hallux. While still assessing barefoot pressure, these studies
adopted an alternative method by using insoles placed in socks, which
participants wore while walking without shoes. Such approach allowed
for multiple steps per trial, without the possibility of altering gait to
ensure contact with any platform.44,47 Sacco et al.36 compared non-
diabetic individuals to patients with diabetic neuropathy; however,
DFU history was not reported. Bacarin et al.30 went further and
included three patient groups: non-diabetic, diabetic neuropathy with
and without history of DFU. Although the diabetic cohorts showed
greater peak pressures at all regions, Sacco et al.36 found only the mid-
foot and forefoot during push-off to be significantly greater, whereas
Bacarin et al.30 found the group with a history of DFU to have signifi-
cantly higher pressure at the midfoot region only, compared to no DFU
history and non-diabetic participant groups. Other regions showed little
difference between diabetes groups. Pressure at the rearfoot also
showed similar values to non-diabetic controls. Such results provide
more detail than previously described whole-foot studies and did not
as perhaps expected, indicate that pressure may differ depending on
location. More research is needed to confirm such results.
2.3 | Barefoot pressure analysis specific to ulcer
location
To the authors' knowledge, there have only been two studies
assessing barefoot pressure at the site of previous ulceration.
Although different in study design, results suggest the location of
ulceration relates to the magnitude of pressure at that particular
site.12,28 A prospective study assessed barefoot plantar pressure using
a pressure platform at the site of previous ulceration, using similar
methods to previously discussed barefoot studies. Patients who re-
ulcerated at the same site within the follow-up period had signifi-
cantly higher pressure than patients who did not re-ulcerate at that
specific site, or ulcerated elsewhere.12 While this study provides an
interesting insight into location specific pressure and re-ulceration,
information on any specific location on the plantar foot or comparison
to a control group is missing. A recent cross-sectional study consid-
ered such limitations and identified a site-specific relationship at the
hallux.28 Barefoot pressure at the hallux, which was measured using
the PressureStat footprint map, was greater for diabetes patients with
a previous hallux DFU, compared to a group of diabetes patients with
a history of ulceration at another site and compared to a group of
non-diabetic controls. The PressureStat, a semi-quantitative footprint
map, is an easy and inexpensive method of highlighting any specific
regions of high plantar pressure, which are determined by comparing
the greyscale of the footprint to a calibration card.48 However, analy-
sis using a visual scale can be subjective, combined with general limi-
tations of barefoot analysis. Therefore, further investigation using less
subjective analysis is required to confirm site-specific relationships
between plantar pressure and DFUs.
Separating plantar pressure analysis into regions may provide
more detail, however barefoot analysis may be open to criticism
because patients with diabetic neuropathy are advised against walking
barefoot, due to the risks of injury; furthermore, barefoot pressure
analysis may not be indicative of pressures experienced on a daily
basis, which ultimately lead to ulceration. Nevertheless, barefoot anal-
ysis does provide a “fundamental” measure of plantar pressures with-
out the potentially confounding/pressure-modifying effects of
footwear and/or orthotics and so for certain purposes may be
informative.
Most daily activity takes place while wearing shoes for patients
with diabetic neuropathy. Gait biomechanics, including plantar pres-
sure, differ between barefoot and shod conditions. Therefore, some
studies suggest that a more ecologically valid approach of analysing
daily life plantar pressure is to do so in shod conditions.34
3 | IN-SHOE PRESSURE ANALYSIS
Individuals with diabetic neuropathy are advised to always wear foot-
wear during daily activities in order to reduce pressure and chance of
trauma to the foot.12,34,49 Studies where both in-shoe and barefoot
pressure are assessed support such guidelines by consistently
reporting plantar pressures to be lower in-shoe.12,34 However,
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patients following these guidelines still ulcerate and so the analysis of
in-shoe pressure is an important feature within the literature.
An example of an in-shoe vertical pressure sensor is shown in
Figure 1. However, developing sensors to measure in-shoe shear pres-
sure has proved to be more of a challenge.50 Although there have
been advancements in the measurement of in-shoe shear pressure,
studies investigating in-shoe shear in relation to DFU are near non-
existent.51
3.1 | In-shoe pressure analysis in relation to
DFU risk
Studies generally show that vertical plantar pressures experienced in-
shoe are lower than barefoot analysis, however those who ulcerate
still have greater in-shoe vertical pressures than cohorts who remain
ulcer-free. Advantages and disadvantages of barefoot and in-shoe
pressure analysis are highlighted in Table 3. A threshold of 200 kPa
for vertical plantar pressure has been suggested within in-shoe pres-
sure research, to highlight those at risk of DFU.34 While the majority
of the cohort's average pressure data remains in line with this thresh-
old, some individuals who remained ulcer-free did have pressure
above the threshold and some who ulcerated had pressures below
this threshold. Furthermore, one study reported 36% of ulcer-free
patients and 51% of patients who ulcerated to have pressures above
the threshold.12
Studies assessing in-shoe pressure tend to be more location-spe-
cific. A few studies focused on in-shoe pressure analysis at the site of
a previous DFU, once again showing similar results to barefoot analy-
sis, however further research is required.12,32,34 To the authors'
knowledge, only one study separated pressure analysis at previous
DFU sites into regions, instead of combining all DFU data.32 Although
the study conducted no statistical analysis to compare pressure data,
the combined pressure at sites of ulceration was higher than pressure
at the same site in non-ulcerated patients. However, when looking at
location-specific data, the hallux and heel, which had the highest DFU
rates along with the metatarsals, had lower peak plantar pressure than
the non-ulcerated cohort, whereas peak plantar pressure was greater
for the ulcerated metatarsals, compared to non-ulcerated. Further-
more, higher baseline peak plantar pressure was only significantly
associated with an increased DFU risk at the metatarsals, potentially
indicating a location-specific relationship at the metatarsals only.
However, although including a large sample size, only five mid-gait
steps per foot were analysed, whereas Arts and Bus52 suggest twelve
steps are required to ensure reliable and valid in-shoe pressure data.
In addition, 50% of the whole cohort and 19% of ulcerated cohort
were non-neuropathic, yet neuropathy is a central risk factor for DFU.
Including non-neuropathic patients gives reason to expect some DFUs
were not neuropathic plantar ulcers and may have developed through
a different pathway, unrelated to plantar pressure, potentially compli-
cating the results. Therefore, further analysis is required to confirm
whether a location-specific pressure and ulceration relationship exists
for neuropathic DFUs.
3.2 | Is in-shoe pressure indicative of pressures
experienced in day-to-day life?
In-shoe pressure analysis removes the need for directed walking over
a pressure platform and allows the analysis of consecutive steps.
Although more indicative of pressures experienced by an individual
with diabetic peripheral neuropathy during daily-life, through incorpo-
rating footwear and insoles, the majority of studies have still only
assessed a “snapshot” of in-shoe pressure during one laboratory visit.
However, one prospective study did assess in-shoe pressure at
follow-up visits, results of which were averaged over two consecutive
visits to indicate loading over the three months in between.12 While
such methods may be more representative than a single measurement
of in-shoe pressure, assumptions concerning the loading between the
3-month study visits may not be evidence-based. Furthermore, in-
shoe pressure data collection involves participants being tethered to
cables, limiting the extent of movement. In addition, as with the
majority of barefoot and in-shoe studies, pressure was assessed dur-
ing level, straight-line walking only and thus may still not be represen-
tative of habitual gait during all daily activities. Nevertheless, a small
number of studies have assessed pressure during additional walking
activities including walking in a circle, ascending and descending a
ramp and staircase.53,54 However, one study included patients with
low levels of foot deformity, no history of foot trauma and no descrip-
tion of any DFU history, thus indicating patients likely had little risk of
plantar ulceration and the associated higher plantar pressures. Such
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patient demographics perhaps contributed to the surprisingly signifi-
cantly greater pressures in all activities for the non-neuropathic partic-
ipants.54 A second study did include higher risk patients, 44% of
whom had a history of DFU, however, no within-patient comparisons
took place and instead the comparably small sample size formed a sin-
gle cohort, to compare pressures between different walking condi-
tions.53 Both studies found level walking to produce the highest
pressures for the most part, but suggested such results may be due to
patients walking slower in other tasks compared to level walking. Fur-
thermore, ecological validity is somewhat questioned for both studies
due to patients wearing standardised shoes, when in fact the majority
of the neuropathic diabetes population wear custom-made shoes.20,55
Further research with larger cohorts of at-risk patients completing dif-
ferent activities is required to confirm such results and improve our
knowledge of pressures experienced on a daily basis.
4 | INFLUENCE OF DAILY ACTIVITY ON
DFU DEVELOPMENT
Research suggests the formula for the development of a DFU includes
the product of plantar pressure and repetitive loading. The amount of
activity an individual undertakes is often used to help estimate the
cumulative pressure exerted on the plantar foot. It has been proposed
that the more active a person with diabetic neuropathy is, the greater
the cumulative pressure exerted and the greater the risk of ulcera-
tion.56 As discussed previously, pressure analysis of the diabetes pop-
ulation has focused on walking; this is also the case for the majority of
studies assessing activity. Studies often record the number of steps
per day as an indication of weight-bearing physical activity.57,58 How-
ever, although increased cumulative loading is thought to lead to a
DFU, studies have shown that patients with a history of DFU walk
significantly fewer steps per day than people with no history of DFU
and healthy controls.56-58 An accelerometer is regularly the device of
choice for measuring activity, however, such data is usually collected
over a short period of time (eg, 1 week) and so may not adequately
capture activity levels of diabetes patients, particularly those who are
at risk of DFU, which are reported to be variable.56 Alternatively,
Lemaster et al.59 used questionnaires to record self-reported activity
of the previous 24 hours, every 17 weeks for two years. Unlike previ-
ously mentioned studies, this study included all weight-bearing activi-
ties, including standing and sitting, which are likely to contribute to
the cumulative pressure exerted on the plantar foot and associated
DFU risk. However, there was limited analysis on the different types
of activity, apart from at baseline, where patients with a prior DFU
spent more hours sitting than walking. Furthermore, Lemaster et al.59
reported no significant differences in weight-bearing activity between
participants who ulcerated within the follow-up and those who did
not, in fact, higher activity levels were reported to reduce the risk of
ulceration, which conflicts previous theories. In addition, participants
with neuropathy were slightly less active than those with intact sensa-
tion; however, such differences were not significant. Although activi-
ties other than walking were considered, activity over the prior
24 hours was assumed to remain constant throughout each 17 week
time period between questionnaires. In addition, the questionnaire
was reported to have strong validity with a step-activity monitor;
however, in terms of distinguishing between different types of
weight-bearing activity, the sensitivity of this measure may be
questionable.
A more sensitive method of distinguishing between activity types
than a questionnaire, is a triaxial accelerometer, as reported by Najafi
et al60 Participants, all of whom had peripheral neuropathy, spent
more time sitting and standing compared to walking, a similar finding
to that suggested by Lemaster et al.59 at baseline. However, results
were not compared to a control group and analysis took place over
48 hours only. Furthermore, there was no mention of any foot defor-
mities or previous DFUs, indicating that participants may have been
lower risk than previously studied cohorts and this was also indicated
by a higher step-count. Nevertheless, such results are promising and
highlight the importance of future studies measuring all types of
weight-bearing activity, as ultimately all contribute to the pressure
and cumulative loading applied to the plantar foot and associated
DFU risk. Future studies should compare the activity of high-risk
patients to controls, with accelerometers worn for a longer duration.
5 | RELEVANCE OF CUMULATIVE
PRESSURE DATA FOR DFU RISK
Although further research is needed, previous studies suggest that
diabetic patients at risk of ulceration spend more time standing and
sitting, than walking.59,60 Individuals are still at risk of ulcerating dur-
ing such weight-bearing activities, yet pressure assessment of the dia-
betes population has been limited to walking only.53,54 Compared to
walking, other weight-bearing activities such as standing typically
have lower peak pressures; however, this pressure is applied for lon-
ger. Prolonged pressure increases the duration of blood occlusion and
the associated plantar tissue ischaemia, increasing the risk of develop-
ing a DFU.61 Therefore, a cumulative measure of pressure applied
over a given time such as pressure-time integral data, which takes into
account loading time, may be more indicative of DFU risk than peak
pressure; however, such analysis only exists for walking.33,62,63
Pressure-time integral data is occasionally reported alongside the
parameter of choice, peak pressure, with conflicting views as to
whether it adds any benefit.63 The majority of studies reporting both
parameters found no differences between them, essentially, any sig-
nificant result or pattern reported for peak pressure was also present
for the pressure-time integral.52,54,64 The few studies that did find dif-
ferences, perhaps indicating a benefit of reporting both, were associ-
ated with some limitations. Differences were only evident at the heel,
likely due to its greater variability during stance compared to other
areas.30,65 The heel is not a typical region of ulceration and so such
result has limited clinical relevance. Furthermore, other studies that
found a difference between parameters did not standardise walking
speed.53,66 Walking speed affects pressure-time integral more than
peak pressure and, if standardised, differences would be expected to
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be minimal. In addition, pressure-time integral data combined with
strides per day was used to estimate cumulative plantar pressure.58
While this may provide a more accurate estimation of cumulative
pressure compared to using either measurement alone, again, the only
activity assessed was walking. Further investigation into pressure
parameters of all weight-bearing activities of daily-life is required.
Peak, pressure-time integral and cumulative pressure data may best
suit different weight-bearing activities, however, conclusions cannot
be made until such analysis has taken place within the diabetes
cohort.
6 | PLANTAR OFFLOADING
INTERVENTIONS FOR THE AT-RISK FOOT
In clinical practice, offloading interventions such as footwear and
insoles are commonly prescribed to reduce high plantar pressure in an
attempt to heal or prevent DFUs. The main purpose of such interven-
tions are to reduce plantar pressure to an active DFU or areas at-risk
of developing a DFU by transferring pressure to other foot regions or
to the offloading device.67-69
As discussed in previous sections, plantar pressure is lower in-
shoe than in barefoot conditions, therefore in an attempt to prevent
ulceration, custom-made therapeutic footwear are commonly pre-
scribed to offload the foot regions of interest; however, ulcerations
still may occur while wearing such footwear.70 Although offloading
high plantar pressures is the main aim of footwear prescription, the
measurement of plantar pressure does often not play a role in foot-
wear design and manufacturing.71,72 Instead, clinical judgement and
foot shape are taken into account, which vary in method, in addition
to a wide variety of materials being used.73 Therefore, due to large
variability within both research and clinical practice, there are no
standardised protocols and so footwear development is often
described as more of an art than a science.71,74,75
Of the many footwear designs available, those with a rocker-
bottom outsole, designed to compensate for minimal movement at
the joints of the foot and ankle, as well as maximise foot contact area,
have consistently been shown to reduce forefoot pressure, whereas
other designs have shown variable results.76-78 To further facilitate
plantar offloading, the inclusion of an insole is a vital component of
therapeutic footwear and has been shown to significantly reduce
plantar pressure compared to footwear alone.79,80 To ensure success-
ful offloading a custom-made insole is desirable over off-the-shelf
alternatives.71,74 Insoles are often customised using an impression of
foot shape and clinical judgement; however, the addition of barefoot
pressure assessment to this design process has seen significant
improvements to offloading capabilities along with a reduction in DFU
recurrence.74,79,81 Barefoot pressure analysis was used to identify
areas of high pressure to guide the insole design process and while for
the most part this was successful, there was evidence of some vari-
ability between individuals, with some seeing no benefit of the addi-
tional barefoot pressure input. The use of barefoot pressure to guide
off-loading taking place in-shoe perhaps might contribute to some of
this variability, as footwear could alter the plantar pressure profile.
Studies that modified insoles based on in-shoe pressure also reported
significant reductions in plantar pressure following modifica-
tions.49,70,72 However, one study found no significant reductions in
DFU occurrences between modified and non-modified insoles,
although it was suggested that this result was due to poor patient
adherence to the footwear; when non-adherent patients were
removed from the analysis a significant reduction in DFUs was identi-
fied.70 In some cases, further modifications were needed to preserve
offloading efficiency over time, however more research on changes
over-time are needed due to inconclusive results.72,82
Continuous offloading is required to combat high reulceration
rates and while custom-made therapeutic footwear, particularly
insoles designed using plantar pressure data, have been effective,
results between individuals vary.83 Further research is needed in order
to produce standardised, reliable protocols in design and modification,
which can be preserved over time.
Typically, footwear and insoles have been the intervention of
choice for reducing high plantar pressures, but a small number of
studies providing feedback on high plantar pressures in an attempt to
replace what is lost through diabetic peripheral neuropathy offer an
alternative intervention (Table. 4).84,86 The majority of studies investi-
gating the provision of pressure feedback in individuals with diabetic
peripheral neuropathy, do so using visual aids. Few studies detail the
methods of providing this feedback, those that do tend to show par-
ticipants a graph of their average pressure and a highlighted target
range usually 40-80% of baseline.84,86 However, in the majority of
studies, the pressure data and associated feedback focus on one at-
risk area only, identified as the location of peak pressure while walk-
ing. Generally, participants take part in a learning period, which con-
sists of walking followed by the provision of feedback, until a new
walking strategy is adopted that offloads the high-risk area to within
the target range. Such studies have reported a significant reduction in
pressure applied to the at-risk area, as a result of a single provision of
feedback, and this pressure reduction remained during the follow-up,
the longest retention period assessed being 10 days.84,86 However,
these studies excluded all foot deformities, whereas York et al.88
assessed a higher risk population, excluding only severe foot deformi-
ties and reported no lasting significant reductions in plantar pressure.
Furthermore, York et al.88 provided visual and verbal feedback con-
cerning the forefoot, rather than one at-risk area. However, a detailed
description of the feedback method was not provided and so cannot
easily be compared to previous studies. In addition, the effect of the
feedback was only assessed over a shorter, one-week retention
period. Nevertheless, such findings suggest participants at higher risk
of ulcerating may require more instances of feedback to elicit a posi-
tive response.
Alternatively, one case study showed promising results for an
individual with an active DFU, where feedback provided was in the
form of an audio alarm that sounded when pressure exceeded a pre-
determined value.85 Following 2 weeks of continuous audio feedback,
the participant's DFU size and plantar pressure had reduced, indicat-
ing a significant clinical improvement. The results of this single-
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participant case study are promising and warrant further investigation
through a randomised control trial to validate these positive findings.
Although the feedback may be simpler for the participant, this system
is again limited to only providing feedback to one area, without the
monitoring of overall pressure distribution across the foot. Few stud-
ies have addressed this limitation and assess overall pressure distribu-
tion in addition to pressure at the specific high-risk area, in order to
identify if any new at-risk areas develop.84,87,88 One study did report
a significant increase in pressure to the contralateral lateral mid-foot
following successful off-loading of the at-risk area.84 Such pressure
increase to the contralateral foot may result in the development of a
new at-risk area should the new strategy be continued. However, due
to the short follow-up, as is the case with all previous feedback stud-
ies, it is unknown whether such changes to participants' plantar pres-
sure will revert to baseline following a prolonged period. Previous
results have shown pressure at the high-risk area to increase slightly
TABLE 4 Characteristics of studies where plantar pressure feedback is provided
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Active ulcer site N 2 weeks 450 200 Reduction n/a 1





70% of steps), 1 lab
visit
1 at-risk area N 10 days 262 (70) 210 (51) Reduction n/a 13
cVan (2017)87 FEETME pressure
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pressure 40–80%
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of steps) - 1 visit
1 at-risk area Y 6 weeks — — Reduction No other at-risk areas
developed
6
d,eYork (2009)88 Visual and verbal
feedback on gait
and forefoot peak
pressure, 2 days of
feedback















No pressure data reported,
DFU recurrence rates reduced
by 71% in the intervention
58
Note: Where plantar pressure data provided mean (SD) kPa *(SE). All patients included in the above studies had diabetic peripheral neuropathy.
aStudies monitored pressure across both feet.
bThis case-study provided feedback continuously for 2 weeks to a single participant with an active foot ulcer. The ulcer size reduced from baseline to end
of retention.
cAlthough a reduction in plantar pressure existed at the end of retention, only 50% of steps were below the maximum pressure threshold (80% of
baseline), instead of the recommended 70% of steps.
dPlantar pressure at the first MTH significantly reduced 1 day after baseline, however at the end of retention there were no significant changes from
receiving feedback.
eThis study randomised patients into 2 groups: feedback and no-feedback. In addition, pressure at 1-5 MTHs and heel were analysed.
fThis study randomised patients into two groups: intervention (receiving continuous pressure feedback) and control (no pressure feedback). Patients in the
intervention group received feedback throughout daily-life when sustained high pressure was detected. No pressure data was reported.
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over the retention period, although remaining significantly lower than
baseline, perhaps suggesting that a gradual return to baseline may be
evident in the absence of sustained feedback.86 Such a result also
gives reason to provide more regular instances of feedback, rather
than providing feedback on a few walking trials, to prevent a return to
baseline. Further research is required to investigate long-term effects
of regular feedback on both plantar pressure reduction and associated
DFU risk.90 With the rise in smart-technology, we are seeing advance-
ments in pressure-feedback systems, whereby pressure is analysed
and feedback provided continuously.91,92 However, such advance-
ments are evident in other treatment areas but until recently were yet
to be implemented within diabetes and DFU prevention. A recent pro-
spective, randomised proof-of-concept trial saw participants wear an
innovative, smart insole system, which provided visual and auditory
plantar pressure feedback to the intervention group during daily-life
activities, while a control group had the same sensors without receiv-
ing any pressure feedback.89 The feedback, which covered eight sen-
sor sites on both feet, was provided via a wrist-worn smart watch to
the intervention group. The smart insole system resulted in a 71%
reduction in DFU recurrence in the intervention group and this rose
to an 86% reduction in the most highly compliant participants. To the
authors' knowledge, this is the first study of its kind to show the
effectiveness of a smart insole system designed to measure sustained
levels of high, but not peak, plantar pressures and guide regular
dynamic offloading in a “real life” situation over a prolonged period
for reducing the risk of DFU recurrence.
7 | CONCLUSIONS AND FUTURE
DIRECTIONS
Diabetic foot ulcers are a public health concern, associated with high
rates of recurrence and the potential to lead to limb amputation.
High plantar pressure is a common risk factor for DFU and patients
with a history of DFU are often found to have greater plantar pres-
sures compared to their non-ulcerated or non-diabetes counter-
parts. Vertical plantar pressure is more commonly assessed,
however, studies do exist reporting shear pressures, which are of a
smaller magnitude and more difficult to assess than the vertical
component. At present, shear pressure is often limited to barefoot
assessment, whereas vertical plantar pressure has been assessed
both barefoot and in-shoe. While in-shoe appears to be the most
applicable to pressures experienced in daily life limitations still exist.
Pressure assessments have been confined to laboratories, with
walking being the only weight bearing activity analysed, thus limiting
ecological validity. Research into the daily-life activities of patients
with diabetic peripheral neuropathy, although limited, indicates that
more time is spent standing and sitting compared to walking. Such
findings suggest that perhaps a measure of cumulative pressure over
time may be more relevant than the commonly used peak pressure
parameter. Custom footwear and insoles are commonly prescribed
to offload high plantar pressures; however, further research into the
use of pressure to design and modify footwear is required before
standardised protocols can be developed. While for the most part,
footwear interventions are effective at offloading, results vary
between individuals and are only effective when worn regularly. The
provision of plantar pressure feedback provides an alternative
approach and shows promising results, however, further research is
required to understand long-term effects of feedback, which con-
siders all areas of the diabetic foot. The introduction of smart-tech-
nology, where pressure can be monitored and feedback can be
provided on a continual basis, offers a promising method for
addressing such shortfalls, with positive results from a randomised
proof-of-concept trial.
Constraints and other considerations with previous methods of
pressure assessment perhaps explain low prediction scores for ulcera-
tion. Further pressure analysis, considering both vertical and shear
components, outside the laboratory during daily life activities and con-
sidering all weight-bearing activities, is required to improve our under-
standing of plantar pressures predisposing ulceration. In addition,
research is required to investigate whether provision of feedback can
result in long-term beneficial effects, which could ultimately reduce
plantar pressure and DFU occurrence.
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